4-Methoxy-N-(3-methylphenyl)benzenesulfonamide | CAS:7230-53-7
            
            4-Methoxy-N-(3-methylphenyl)benzenesulfonamide
            - Name:4-Methoxy-N-(3-methylphenyl)benzenesulfonamide
 - CAS:7230-53-7
 - Synonyms:4-Methoxybenzenesulfono-m-toluidide
 - Molecular Formula:C14H15NO3S
 - Molecular Weight:277.34
 - EINESC:
 
Description
Properties
| Density | 1.267±0.06 g/cm3 (20 º | 
|---|
Safety
| 没有数据 | 没有数据 | 
|---|
SDS
| Source | SDS/MSDS Samples | 
|---|---|
| 没有数据 | 没有数据 | 
Synthetic Route
                | Name | CAS | 
|---|
More
            Articles
                Peer-Reviewed Papers
                
                                        Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals.Ilaria Massarelli et al.European journal of medicinal chemistry, 44(9), 3658-3664 (2009-03-11)
                                        Histopathology of carcinomas of the liver in mice fed perthane.M D Reuber Tumori, 66(3), 277-283 (1980-06-30)
                                        O,P'DDD IN THE TREATMENT OF ADVANCED MAMMARY CARCINOMA.S WEISENFELD et al.Cancer, 17, 1258-1266 (1964-10-01)
                                        Potential compounds for monitoring method performance in the determination of selected organochlorine pesticides and polychlorinated biphenyls in human serum.V W Burse et al.Journal of analytical toxicology, 14(3), 143-145 (1990-05-01)
                                        Investigation of the feasibility of TiO(2) nanotubes for the enrichment of DDT and its metabolites at trace levels in environmental water samples.Qingxiang Zhou et al.Journal of chromatography. A, 1147(1), 10-16 (2007-03-10)
                                        Rapid decline of persistent organochlorine pollutants in serum among young Swedish males.Anna Axmon et al.Chemosphere, 70(9), 1620-1628 (2007-09-12)
                                        Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention.Lisa Krenn et al.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 84(7), 1029-1039 (2014-01-10)
                                    
            Remarks
                
            Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
| Name | CAS | 
|---|
        
Related Products
Related News
Question
    Hot Tags
    Inquiry
Fill in related informations ;please!
- Please fill in product name !
 - CAS
 - Please fill in your company information correctly!
 - Please fill in liaison information correctly!
 - Please fill in your telephone number correctly!
 - Please fill in your email correctly!
 - Please describe the problem of products!